Evaluation of cognitive profile and subclinical vascular damage in subjects with genetically confirmed familial

Sabrina Scilletta1, Nicoletta Miano1, Maurizio Di Marco1

  • 1Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

PubMed

Insights

Familial hypercholesterolemia (FH) is linked to cognitive impairment, with higher vascular damage markers like pulse wave velocity (PWV) and intima-media thickness (IMT) found in affected individuals. This suggests subclinical vascular damage contributes to cognitive decline in FH patients.

Area of Science:

  • Cardiology
  • Neurology
  • Genetics

Background:

  • Familial hypercholesterolemia (FH) involves high LDL cholesterol, accelerating atherosclerosis.
  • The relationship between elevated LDL cholesterol and cognitive impairment requires further investigation.
  • This study examines cognitive impairment prevalence in FH patients and its link to vascular damage.

Purpose of the Study:

  • To assess cognitive impairment prevalence in genetically confirmed FH subjects.
  • To investigate the association between cognitive function and subclinical vascular damage in FH.
  • To identify factors contributing to cognitive decline in FH patients.

Main Methods:

  • A cross-sectional study of 253 FH subjects (18-75 years) without prior cognitive disorders.
  • Cognitive function assessed using the Short Blessed Test (SBT), stratifying into normal (NC) and impaired (IC) cognition groups.
  • Vascular parameters including pulse wave velocity (PWV) and intima-media thickness (IMT) were measured.

Main Results:

  • The impaired cognition (IC) group was older and had higher hypertension rates and DLCN scores.
  • Significantly elevated PWV and IMT were observed in the IC group compared to the normal cognition (NC) group.
  • Cognitive impairment was independently associated with increased PWV (OR 1.32 [1.06-1.66], p = 0.012).

Conclusions:

  • FH patients with cognitive impairment show increased PWV and IMT.
  • Subclinical vascular damage appears to be an independent factor in cognitive decline among FH subjects.
  • These findings highlight the importance of vascular health in maintaining cognitive function in FH.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
474
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
557
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
322
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
757
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
925